Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-10-25FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for Methotrexate by Hikma Pharmaceuticals USA Inc., enabling a new generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis [Phase 4]
Phase 4 trial update on ticagrelor in methotrexate-resistant rheumatoid arthritis has completed with results posted.
-
FDA approval · 2021-10-22FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Actemra (tocilizumab) from Genentech, expanding its labeling and/or indications. The action conf…
-
FDA approval · 2021-10-15FDA Approved: ADALIMUMAB-ADBM — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approves a supplemental application for the adalimumab biosimilar ADALIMUMAB-ADBM from Quallent Pharmaceuticals Health LLC. The approval…
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis [Phase 2]
A Phase 2 trial evaluating the EP4 antagonist CR6086 combined with methotrexate in DMARD-naïve patients with early rheumatoid arthritis has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: TL011 in Severe, Active Rheumatoid Arthritis Patients [Phase 1]
Phase 1 trial update for TL011 in severe, active rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients [Phase 2]
Phase 2 trial update for SHR0302 tablets as monotherapy in active rheumatoid arthritis (RA) has been completed.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Evaluation of the Condition of Rheumatoid Arthritis After Treatment [Phase 4]
Phase 4 clinical trial update evaluating the condition of rheumatoid arthritis after treatment.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Usefulness of Non TNF Usage in RA Patients [Phase 2]
Phase 2 trial investigating the usefulness of non-TNF therapies in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Examination of Efficacy and Safety of Baricitinib in RA Patients [Phase 2]
Phase 2 trial examining efficacy and safety of baricitinib in rheumatoid arthritis patients.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib [Phase 2]
Phase 2 trial in rheumatoid arthritis patients completed; study terminated with results posted in 2021.
-
FDA approval · 2021-09-14FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for hydroxychloroquine sulfate from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 3]
A Phase 3 trial comparing CT-P13 (biosimilar infliximab) to China-approved Remicade when co-administered with methotrexate in active rheumat…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
A completed clinical trial evaluating response to Enbrel and the impact of RF and anti-CCP in rheumatoid arthritis patients, with results po…
-
FDA approval · 2021-08-23FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Ipca Laboratories Limited)
The FDA approved a supplemental application for hydroxychloroquine sulfate from Ipca Laboratories Limited, approving changes to an already-a…
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics [Phase 2]
Phase 2 study of E6011 in rheumatoid arthritis patients inadequately responding to biologics has completed with posted results.
-
FDA approval · 2021-08-23FDA Approved: PENICILLAMINE — Original Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's penicillamine under its original application (ANDA 215409), enabling a generic version of pen…
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial results for an oral p38 inhibitor in active rheumatoid arthritis assessing safety, efficacy, and pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis [Phase 4]
A Phase 4 safety study comparing tofacitinib with a TNF inhibitor in rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis? [Phase 2]
Phase 2 trial investigating whether sildenafil improves endothelial dysfunction in rheumatoid arthritis; study terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA [Phase 1, Phase 2]
Phase 1/2 trial evaluating escalating IV doses of tilmanocept with SPECT imaging in subjects with and without rheumatoid arthritis; study co…
-
FDA approval · 2021-08-02FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Diclofenac Sodium and Misoprostol from Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease [Phase 3]
Phase 3 trial evaluating two dosing regimens of olokizumab versus placebo in rheumatoid arthritis patients on TNF inhibitor therapy; study c…
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases [Phase 2]
Phase 2 clinical trial evaluating low-dose IL-2 to induce regulatory T cells in various autoimmune and inflammatory diseases; trial complete…
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA) [Phase 2]
Phase 2 trial evaluating ABBV-3373 in moderate to severe rheumatoid arthritis has completed with posted results.